Drug Profile
Etanercept - BetterLife Pharma
Alternative Names: NK-001; NP-1 - BetterLife Pharma; NP1Latest Information Update: 17 Nov 2021
Price :
$50
*
At a glance
- Originator Neurokine Pharmaceuticals
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Disease-modifying antirheumatics; Recombinant fusion proteins; Skin disorder therapies
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 05 Dec 2019 Pivot Pharmaceuticals is now called BetterLife Pharma
- 28 Feb 2018 No recent reports of development identified for clinical-Phase-Unknown development in Cognition-disorders in South Africa